|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||10.85 / 33.82|
The Dow, S&P 500 and Nasdaq all rose on Wednesday.
Berkshire Hathaway hiked its stake in the drugmaker, which is undergoing a restructuring, to 40.5 million shares as of the end of March.
The Israel-based drugmaker reported first-quarter numbers that surpassed analysts' expectations but Wall Street wants to see more.
Shares of Tesla Inc., which reported earnings on Wednesday, fell by 5.5%
Teva shares edged into positive territory for the year Thursday after a stronger-than-expected start to the year allowed CEO Kåre Schultz to boost the generic drugmaker's 2018 earnings forecast.
Jim Cramer shines a spotlight on McDonald's, Nucor, Ball Corp. United States Steel, Teva Pharmaceuticals, Chicago Mercantile Exchange and more.
Jim Cramer says he's still optimistic, and he doesn't want investors to give up. But he has 12 reasons to also remain cautious -- especially about Fridays.
The tough news keeps coming at the generic drug company, which announced last week it was considering putting itself up for sale. Now the Justice Department wants a chat.
Procter & Gamble will pay around $4.2 billion for the consumer healthcare unit of Merck KGaA in the first major deal for the group since activist investor Nelson Peltz joined the board last month.
Following Wednesday's event, Leerink analyst Ami Fadia said she is 'incrementally more positive' on the drugmaker's pipeline and diversified business model and moved her rating to outperform.
While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.
As President Trump tees up a set of 25% tariffs on a wide range of products against China trade, generic drug makers as well as their patients likely will be affected.
RBC's Randall Stanicky says concerns have moved from being about global generic growth to Teva's branded drug business.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Lialda ®1 (mesalamine) delayed-release tablets, 1.
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the launch of a generic version of ALOXI ®1 (palonosetron HCI) injection, 0.
Novartis subsidiary Sandoz Canada will work with cannabis producer Tilray to produce non-smokable medical cannabis products in Canada, becoming the first Big Pharma company to get into medical pot.
President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Cowen & Company 38 th Annual Healthcare Conference in Boston, MA.
A massive price-fixing lawsuit brought by 45 states against a group of generic drug producers as well as a changing of the guard at the Food and Drug Administration may lead to changes in the generic drug sector.
Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) ("Teva") announced today that it successfully priced the offering of $4.
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
Here's what you need to know now for Tuesday, March 6.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.